Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$914K Sell
31,403
-719
-2% -$18.6K ﹤0.01% 1643
2020
Q3
$707K Buy
32,122
+333
+1% +$8.49K ﹤0.01% 1616
2020
Q2
$885K Buy
31,789
+6,147
+24% +$150K ﹤0.01% 1473
2020
Q1
$470K Buy
25,642
+2,404
+10% +$55.9K ﹤0.01% 1682
2019
Q4
$560K Buy
23,238
+511
+2% +$10.8K ﹤0.01% 1739
2019
Q3
$388K Sell
22,727
-1,691
-7% -$27K ﹤0.01% 1891
2019
Q2
$367K Sell
24,418
-3,933
-14% -$70.3K ﹤0.01% 1934
2019
Q1
$570K Sell
28,351
-145
-0.5% -$2.94K ﹤0.01% 1672
2018
Q4
$507K Buy
28,496
+4,687
+20% +$83.3K ﹤0.01% 1666
2018
Q3
$468K Sell
23,809
-1,656
-7% -$34.1K ﹤0.01% 1799
2018
Q2
$504K Buy
25,465
+1,810
+8% +$39.8K ﹤0.01% 1741
2018
Q1
$582K Sell
23,655
-1,213
-5% -$31.9K ﹤0.01% 1616
2017
Q4
$714K Buy
24,868
+3,579
+17% +$113K ﹤0.01% 1513
2017
Q3
$582K Sell
21,289
-2,422
-10% -$53.6K ﹤0.01% 1584
2017
Q2
$497K Buy
+23,711
New +$501K ﹤0.01% 1666

Other funds holding ACLS

Aperio Group's ACLS Position: Q4 2020 in Review

Aperio Group reduced its Axcelis (ACLS) stake by 2.2% in Q4 2020, selling an estimated $18.6K and leaving 31,403 shares worth $914K. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

Aperio Group first reported a position in ACLS in Q2 2017 and has held it in 15 quarters since. 171 funds tracked by Wall St. Rank hold ACLS as of Q4 2020.

  • Aperio Group held 31,403 shares of Axcelis worth $914K as of Q4 2020.
  • Aperio Group sold 719 Axcelis shares in Q4 2020, an estimated $18.6K.
  • Axcelis made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1643 holding.
  • Aperio Group first reported a position in Axcelis in Q2 2017 and has held it in 15 quarters since.
  • 171 funds tracked by Wall St. Rank held Axcelis as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.